News about

Godrej Appliances forays into the health and hygiene space with Godrej VIROSHIELD 4.0a

Godrej Appliances forays into the health and hygiene space with Godrej VIROSHIELD 4.0a

The COVID 19 pandemic has made a significant change in Indian consumer behavior when it comes to the priority accorded to safety and hygiene. Consumers are doing their best to protect themselves from the COVID 19 virus

| 20/08/2020 | By 654

Dr Reddy's Lab launches Avigan for COVID-19 treatment

Dr Reddy's Lab launches Avigan for COVID-19 treatment

Dr Reddy's Laboratories Ltd announced the launch of Avigan (favipiravir) 200 mg tablets in India for the treatment of patients with mild to moderate COVID-19 disease

| 19/08/2020 | By 759

PathogenDx receives NIH grant to develop more accurate and f efficient COVID-19 diagnostic testing technology

PathogenDx receives NIH grant to develop more accurate and f efficient COVID-19 diagnostic testing technology

PathogenDx Inc, an Arizona-based technology company which has developed an ultra-accurate DNA-based customized pathogen testing platform for the food, agricultural and health sectors, announced that it has received a second grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the National Institutes of Health (NIH)

| 19/08/2020 | By 559

Medtronic to invest Rs. 1,200 crore to expand its R&D centre in Hyderabad

Medtronic to invest Rs. 1,200 crore to expand its R&D centre in Hyderabad

With Hyderabad fast emerging as Indias hub for medical devices manufacturing, the US-based Medtronic has decided to further consolidate its base in India in the medical devices manufacturing sector. As part of this, the company has decided to invest Rs. 1,200 crore to scale up and expand its current R&D centre into a state-of-the-art engineering

| 17/08/2020 | By 478

Amazon India unveils e:pharmacy platform in Bengaluru, pilots likely in other cities

Amazon India unveils e:pharmacy platform in Bengaluru, pilots likely in other cities

The Amazon Pharmacy service has currently opened in Bengaluru. The company plans its foray into other metros thereafter. Customers can now order via its platform: amazon.in all medicines via prescription. In addition nutraceuticals supplements, Ayurveda medicines and medical devices can also be ordered

| 14/08/2020 | By 419

Aurobindo Pharma Q1 net profit rises by 22.8% to Rs. 780.6 crore

Aurobindo Pharma Q1 net profit rises by 22.8% to Rs. 780.6 crore

Aurobindo Pharma registered a 22.8 per cent year-on-year rise in net profit at Rs. 780.6 crore for the first quarter ended June 2020

| 13/08/2020 | By 413

Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha Join Lupin Board as Independent Directors

Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha Join Lupin Board as Independent Directors

Pharma major Lupin Limited (Lupin) announced today the appointment of Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha as Independent Directors.

| 13/08/2020 | By 534

Alembic Pharma gets US FDA approval for generic Levitra tablets

Alembic Pharma gets US FDA approval for generic Levitra tablets

Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) vardenafil hydrochloride tablets, 2.5 mg (base), 5 mg (base), 10 mg (base), and 20 mg (base)

| 06/08/2020 | By 656

Glenmark Pharma introduces 400 mg version of FabiFlu for COVID-19 treatment

Glenmark Pharma introduces 400 mg version of FabiFlu for COVID-19 treatment

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced that it will introduce a 400 mg version of oral antiviral FabiFlu, for the treatment of mild to moderate COVID-19 in India. The higher strength will improve patient compliance and experience, by effectively reducing the number of tablets that patients

| 06/08/2020 | By 510

Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US

Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US

Lupin and Granules India are recalling close to 9.71 lakh bottles of generic diabetes drug in the US due to the possibility of the affected lot containing cancer-causing nitrosodimethylamine (NDMA) above the acceptable intake limit

| 27/07/2020 | By 462

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members